KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Evolent Health (EVH) Equity Average (2016 - 2025)

Historic Equity Average for Evolent Health (EVH) over the last 11 years, with Q3 2025 value amounting to $869.1 million.

  • Evolent Health's Equity Average fell 1693.19% to $869.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $869.1 million, marking a year-over-year decrease of 1693.19%. This contributed to the annual value of $1.0 billion for FY2024, which is 736.03% up from last year.
  • Latest data reveals that Evolent Health reported Equity Average of $869.1 million as of Q3 2025, which was down 1693.19% from $915.8 million recorded in Q2 2025.
  • In the past 5 years, Evolent Health's Equity Average registered a high of $1.1 billion during Q2 2023, and its lowest value of $610.8 million during Q3 2021.
  • In the last 5 years, Evolent Health's Equity Average had a median value of $915.8 million in 2025 and averaged $871.3 million.
  • Per our database at Business Quant, Evolent Health's Equity Average plummeted by 3035.95% in 2021 and then soared by 8091.7% in 2023.
  • Evolent Health's Equity Average (Quarter) stood at $650.6 million in 2021, then skyrocketed by 31.85% to $857.8 million in 2022, then rose by 26.13% to $1.1 billion in 2023, then dropped by 5.72% to $1.0 billion in 2024, then fell by 14.79% to $869.1 million in 2025.
  • Its Equity Average stands at $869.1 million for Q3 2025, versus $915.8 million for Q2 2025 and $968.4 million for Q1 2025.